Todd, Anna
Satriano, Alessandro
Fenwick, Kate
Merchant, Naeem
Lydell, Carmen P.
Howarth, Andrew G.
Friedrich, Matthias G.
Anderson, Todd J.
Fine, Nowell M.
White, James A.
Funding for this research was provided by:
Heart and Stroke Foundation of Alberta
Article History
Received: 6 April 2018
Accepted: 31 July 2018
First Online: 4 August 2018
Compliance with Ethical Standards
:
: Dr. Anna Todd has no conflict of interest. Dr. Alessandro Satriano declares that he has no conflict of interest. Ms. Kate Fenwick declares that she has no conflict of interest. Dr. Naeem Merchant declares that he has no conflict of interest. Dr. Carmen P. Lydell declares that she has no conflict of interest. Dr. Andrew G. Howarth receives consulting fees from Amgen. Dr. Matthias G. Friedrich is Chief Medical Officer of Circle Cardiovascular Inc. Dr. Todd J. Anderson declares that he has no conflict of interest. Dr. Nowell M. Fine receives consulting fees from Novartis and Pfizer. Dr. James A. White received salary support from the Heart and Stroke Foundation during this study, received research grants from Circle Cardiovascular Inc., and is a shareholder of Cohesic Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.